Det bør også overvejes at afbryde behandlingen med Truvada hos patienter med kreatinin - clearance på under < 50 ml/ min eller fald i serumfosfat til < 1, 0 mg/ dl (0, 32 mmol/ l).
Consideration should also be given to interrupting treatment with Truvada in patients with creatinine clearance decreased to < 50 ml/ min or decreases in serum phosphate to < 1.0 mg/ dl (0.32 mmol/ l).